Tegoprazan is a potassium-competitive acid blocker (P-CAB) that functions by reversibly inhibiting the H+/K+-ATPase enzyme in gastric parietal cells, offering a potent and rapid approach for treating acid-related… Read more
![Chemical structure of 7-Hydroxy-2-methyl-1H-benzo[d]imidazole-5-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1784661-23-9-7-Hydroxy-2-methyl-1H-benzodimidazole-5-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 7-Hydroxy-N,N,2-trimethyl-1H-benzo[d]imidazole-5-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2168520-25-8-7-Hydroxy-NN2-trimethyl-1H-benzodimidazole-5-carboxamide.png&w=3840&q=75)

![Chemical structure of Ethyl 1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1640981-16-3-Ethyl-1-benzyl-4-hydroxy-2-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)
![Chemical structure of Ethyl 4-acetoxy-1-benzyl-2-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1640981-11-8-Ethyl-4-acetoxy-1-benzyl-2-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)
![Chemical structure of Methyl 1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FMethyl-1-benzyl-4-hydroxy-2-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)


![Chemical structure of Methyl 7-bromo-2-methyl-1H-benzo[d]imidazole-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2091562-05-7-Methyl-7-bromo-2-methyl-1H-benzodimidazole-5-carboxylate.png&w=3840&q=75)


![Chemical structure of Potassium (S)-4-((5,7-difluorochroman-4-yl)oxy)-2-methyl-1H-benzo[d]imidazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FPotassium-S-4-57-difluorochroman-4-yloxy-2-methyl-1H-benzodimidazole-6-carboxylate.png&w=3840&q=75)


![Chemical structure of Sodium 2-methyl-7-oxido-1H-benzo[d]imidazole-5-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FSodium-2-methyl-7-oxido-1H-benzodimidazole-5-carboxylate.png&w=3840&q=75)




























Tegoprazan is a potassium-competitive acid blocker (P-CAB) that functions by reversibly inhibiting the H+/K+-ATPase enzyme in gastric parietal cells, offering a potent and rapid approach for treating acid-related disorders such as gastroesophageal reflux disease (GERD) and erosive esophagitis. Laboratories utilize this collection of Tegoprazan reference standards, including structurally related impurities and metabolites, to ensure rigorous quality control and regulatory compliance. These compounds are essential for impurity profiling, allowing for the precise identification and quantification of degradation products formed during synthesis or storage. Furthermore, stable isotope labelled compounds are vital for advancing analytical method validation and supporting accurate bioanalytical studies, such as LC-MS/MS, where they serve as internal standards to minimize analytical uncertainty. By providing these highly characterized materials, the catalogue enables reliable assessment of drug substance purity, stability, and safety throughout the entire pharmaceutical development lifecycle.